Immunohistochemical expression of vascular endothelial growth factor (VEGF) and C-KIT in cutaneous melanocytic lesions

被引:30
作者
Stefanou, D [1 ]
Batistatou, A [1 ]
Zioga, A [1 ]
Arkoumani, E [1 ]
Papachristou, DJ [1 ]
Agnantis, NJ [1 ]
机构
[1] Univ Ioannina, Dept Pathol, GR-45110 Ioannina, Greece
关键词
VEGF; c-kit; nevus; melanoma;
D O I
10.1177/106689690401200206
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Vascular endothelial growth factor (VEGF) and C-KIT are involved in tumor progression in several human neoplasms. The aim of the present Study has been to investigate their immunohistochemical expression in melanocytic lesions. We examined 11 compound nevi, 12 dysplastic nevi, and IS melanomas. Immunostaining for VEGF was observed only in melanomas; c-kit expression was detected in melanomas (higher in radial than in vertical growth phase) and in nevi (predominantly in the junctional component). Our data indicate that assessment of VEGF expression might aid in the differential diagnosis between dystplastic nevi and melanomas. Moreover, VEGF might be a candidate for targeted therapy. The loss of c-kit expression might contribute to melanoma progression.
引用
收藏
页码:133 / 138
页数:6
相关论文
共 28 条
[1]   Expression of AP-2 transcription factor and of its downstream target genes c-kit, E-cadherin and p21 in human cutaneous melanoma [J].
Baldi, A ;
Santini, D ;
Battista, T ;
Dragonetti, E ;
Ferranti, G ;
Petitti, T ;
Groeger, AM ;
Angelini, A ;
Rossiello, R ;
Baldi, F ;
Natali, PG ;
Paggi, MG .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2001, 83 (03) :364-372
[2]   Gene regulation in melanoma progression by the AP-2 transcription factor [J].
Bar-Eli, M .
PIGMENT CELL RESEARCH, 2001, 14 (02) :78-85
[3]  
Bayer-Garner IB, 1999, MODERN PATHOL, V12, P770
[4]  
DIAZFLORES L, 1994, HISTOL HISTOPATHOL, V9, P807
[5]   Protein tyrosine kinases in malignant melanoma [J].
Easty, DJ ;
Bennett, DC .
MELANOMA RESEARCH, 2000, 10 (05) :401-411
[6]   ABNORMAL PROTEIN-TYROSINE KINASE GENE-EXPRESSION DURING MELANOMA PROGRESSION AND METASTASIS [J].
EASTY, DJ ;
HERLYN, M ;
BENNETT, DC .
INTERNATIONAL JOURNAL OF CANCER, 1995, 60 (01) :129-136
[7]   The biology of vascular endothelial growth factor [J].
Ferrara, N ;
DavisSmyth, T .
ENDOCRINE REVIEWS, 1997, 18 (01) :4-25
[8]   MOLECULAR AND BIOLOGICAL PROPERTIES OF THE VASCULAR ENDOTHELIAL GROWTH-FACTOR FAMILY OF PROTEINS [J].
FERRARA, N ;
HOUCK, K ;
JAKEMAN, L ;
LEUNG, DW .
ENDOCRINE REVIEWS, 1992, 13 (01) :18-32
[9]   WHAT IS THE EVIDENCE THAT TUMORS ARE ANGIOGENESIS DEPENDENT [J].
FOLKMAN, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (01) :4-6
[10]   Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis [J].
Huang, S ;
Jean, D ;
Luca, M ;
Tainsky, MA ;
Bar-Eli, M .
EMBO JOURNAL, 1998, 17 (15) :4358-4369